lkb1 modulates lung cancer differentiation metastasis 
germline mutation serine/ threonine kinase stk11 also called lkb1 results peutz jeghers syndrome characterized intestinal hamartomas increased incidence epithelial cancers1 although uncommon sporadic cancers2 inactivating somatic mutations lkb1 reported primary human lung adenocarcinomas derivative cell lines3- used somatically activatable mutant kras driven model mouse lung cancer compare role lkb1 tumour suppressors lung cancer although kras mutation cooperated loss p53 ink4a/ arf also known cdkn2a system strongest cooperation seen homozygous inactivation lkb1 lkb1 deficient tumours demonstrated shorter latency expanded histological spectrum adeno- squamous large cell carcinoma frequent metastasis compared tumours lacking p53 ink4a/ arf pulmonary tumorigenesis also accelerated hemizygous inactivation lkb1 consistent findings inactivation lkb1 found % % analysed human lung adenocarcinomas squamous cell carcinomas respectively expression profiling human lung cancer cell lines mouse lung tumours identified variety metastasis-promoting genes nedd9 vegfc cd24 targets lkb1 repression lung cancer studies establish lkb1 critical barrier pulmonary tumorigenesis controlling initiation differentiation metastasis 
